Ventures Lundbeckfonden Ventures 9. marts 2016 Veloxis Pharmaceuticals A/S moves Danish activates to the U.S. Lundbeckfonden Ventures 9. marts 2016 Veloxis Pharmaceuticals publishes Annual Report 2015 Lundbeckfonden Ventures 7. marts 2016 Vtesse, Inc. Announces Phase 1/2 Clinical Data Showing Slowing of Disease Progression from VTS-270 Treatment for Niemann-Pick Type C1 Disease Lundbeckfonden Ventures 3. marts 2016 scPharmaceuticals Announces Positive Results from Pivotal Trial of Second Program – Subcutaneous Ceftriaxone for Treatment of Bacterial Infections Lundbeckfonden Ventures 2. marts 2016 BONESUPPORTT ANNOUNCES AVAILABILITY IN EUROPE OF CERAMENTT’G IN 5 mL VOLUME TO ADDRESS GROWING MARKET DEMAND Lundbeckfonden Ventures 2. marts 2016 DySIS Medical Signs Significant Deal with ITEM Medical Technologies to Support National Screening Programme in Turkey Lundbeckfonden Ventures 2. marts 2016 Cydan Development Celebrates Rare Disease Day with Gift to Support the NORD Natural History Project Lundbeckfonden Ventures 2. marts 2016 Ziarco Pharma Ltd: Appointment of Dr. Arvind Hundal as Chief Business Officer Lundbeckfonden Ventures 2. marts 2016 Veloxis appoints Alastair McEwan as new Chief Operating Officer Lundbeckfonden Ventures 5. februar 2016 BONESUPPORTT REPORTS EXPANSION OF COMPANY’S CERAMENTT DRUG ELUTING PROCEDURE REGISTRY Sideinddeling Første side « Første Forrige side ‹‹ … Side 33 Side 34 Side 35 Side 36 Nuværende side 37 Side 38 Side 39 Side 40 Side 41 … Næste side ›› Sidste side Sidste »
